TotalMarketCap

Alto Neuroscience

ANRONYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$860.972 M

$21.94 -5.84%

Close of 6 Nov 2026

As of 6 Nov 2026, Alto Neuroscience (ANRO) has a market capitalization of $861.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$63.2M

Loss-making

Shares outstanding

39,242,104

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #150Oric PharmaceuticalsORIC$883.1M
  2. #151Latigo BiotherapeuticsLTGO$865.9M
  3. #152Alto NeuroscienceANRO$861.0M
  4. #153InventivaIVA$857.7M
  5. #154City TherapeuticsCTY$855.1M

What if Alto Neuroscience were worth as much as…

Open the what-if tool →

Gold $28.2T

$719,555.55

Per share 32,797× higher

Bitcoin $1.53T

$38,933.90

Per share 1,775× higher

Apple $5.02T

$127,816.35

Per share 5,826× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Alto Neuroscience are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.